Triglycerides and risk for coronary artery disease.

Current Atherosclerosis Reports
Patrick McBride

Abstract

Triglycerides (TGs) are now considered an independent risk factor for cardiovascular disease (CVD). When TGs are elevated, lipoprotein metabolism is altered, which increases CVD risk. Patients with elevated TGs and low high-density lipoprotein are at particularly high risk of CVD. TGs are often associated with other CVD risk factors, such as obesity, insulin resistance, diabetes mellitus, low HDL cholesterol, lifestyle factors, and changes in lipoprotein size and density. Elevated TGs remain an independent risk even when controlling for the other factors and are a greater risk for women than men. Treatment of elevated TGs in clinical trials has been shown to reduce CVD events, cardiac deaths, and total mortality.

References

Jan 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M A Austin
Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Jan 10, 1996·JAMA : the Journal of the American Medical Association·R G Bakker-ArkemaD M Black
Apr 4, 1998·The American Journal of Cardiology·S M Grundy
Apr 13, 2001·JAMA : the Journal of the American Medical Association·S J RobinsUNKNOWN VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial
Jan 5, 2002·The New England Journal of Medicine·B G BrownJ J Albers
Nov 7, 2002·The American Journal of Cardiology·James D OtvosWilliam C Cromwell
Sep 29, 2004·Diabetes Care·Earl S FordAli H Mokdad
Oct 2, 2004·Clinical Chemistry·Attila BrehmMichael Roden
Oct 20, 2004·Circulation·A PatelUNKNOWN Asia Pacific Cohort Studies Collaboration
Apr 6, 2005·Journal of the American College of Cardiology·Paul N HopkinsEliot A Brinton
Jul 16, 2005·Journal of Internal Medicine·L A Carlson
Mar 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Anatol Kontush, M John Chapman
Apr 19, 2007·The Journal of Clinical Endocrinology and Metabolism·Kenneth J MukamalDavid S Siscovick
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Sandeep BansalPaul M Ridker
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Patrick E McBride
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Erik IngelssonRamachandran S Vasan
Sep 19, 2007·Annals of Internal Medicine·Amir TiroshIris Shai
Jan 30, 2008·Circulation·H Robert Superko, Spencer King
Feb 19, 2008·Journal of the American College of Cardiology·Michael MillerUNKNOWN PROVE IT-TIMI 22 Investigators
Mar 11, 2008·The American Journal of Cardiology·Destry SulkesWilliam C Roberts

❮ Previous
Next ❯

Citations

Apr 6, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Galin V MichailovKarl J Krobot
Jul 20, 2010·Journal of Thrombosis and Thrombolysis·David KarasekDalibor Novotny
Jan 29, 2014·European Journal of Endocrinology·Antonio GiordanoSaverio Cinti
Feb 26, 2013·Nutrients·Jon O Ebbert, Michael D Jensen
Mar 10, 2015·Computational and Structural Biotechnology Journal·Mark T Mc Auley, Kathleen M Mooney
Jul 14, 2010·Archives of Cardiovascular Diseases·Jean FerrièresVanina Bongard
Sep 18, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kazuhiko KotaniAlan T Remaley
May 24, 2017·Human & Experimental Toxicology·A M HegazyEm El Sayed
Aug 16, 2018·Journal of Lipid Research·Prashantha HebbarThangavel Alphonse Thanaraj
Feb 23, 2019·Journal of the American College of Nutrition·Chin-Lin HsuYen-Lien Chen
Oct 4, 2018·Current Vascular Pharmacology·John C StevensonNick Panay
Nov 26, 2015·Journal of Complementary & Integrative Medicine·Ramalingam SripradhaNachimuthu Maithilikarpagaselvi
Mar 3, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Karen Y StokesNathan S Bryan
Jan 10, 2019·Journal of Biomedical Science·Jonatas Rafael de OliveiraLuciane Dias de Oliveira
Jul 23, 2013·Biological Research for Nursing·Raildo da Silva CoqueiroAline Rodrigues Barbosa
Feb 8, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Ifeanacho Mercy OnuekwuzuIkewuchi Jude Chigozie
Jan 17, 2020·Cardiovascular Diabetology·Javad AlizargarShu-Fang Vivienne Wu
Aug 20, 2020·Korean Circulation Journal·Su Hyun LeeSun Ha Jee
Aug 20, 2017·International Journal of Legal Medicine·Charlotte GirardCristian Palmiere
Mar 29, 2019·Food Science & Nutrition·Catherine C IkewuchiMercy O Ifeanacho
Apr 2, 2010·Journal of Agricultural and Food Chemistry·R Di BenedettoS Salvati
Aug 8, 2021·International Journal of Molecular Sciences·Yang WuPing Song
Sep 4, 2021·Vaccine·Alexandra FowlerBryce Chackerian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.